Руководство Британского торакального общества по ведению больных с предполагаемой тромбоэмболией легочных артерий

1. British Thoracic Society. Suspected acute pulmonary embolism: a practical approach. Thorax 1997; 52 [suppl. 4): Sl–S24. Available from http://www.brit-thorcacic.org.uk /guide1/download_guide, htmll#embolism.

2. Harbour R., Miller J. A new system for grading recommen- dations in evidence basod guidelines. Br. Med. J. 2001; 323: 334–336.

3. Knottnerus J.A., von Wed C., Muris J.W. Evaluation of diagnostic procedures. Br. Med. J. 2002; 324: 477–480.

4. Goldhaber S.Z., Grodstein F., Stampfer M.J. et al. A pros- pective study of risk factors for pulmonary embolism in women. JAMA 1997; 277: 642–645.

5. Hansson P.O., Eriksson H., Welin L. et al. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men. Arch. Intern. Med. 1999; 159: 1886–1890.

6. Rosendaal F.R. Venous thrombosis: a multicausal disease. Lancet 1999; 353:1167–1173.

7. Blasiyk H, Bjornsson J. Factor V Leiden and morbid obesi- ty in fatal postoperative pulmonary embolism. Arch. Surg. 2000; 135:1410–1413.

8. Former R., Lawrenson R., Todd J. et al. A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives. Br. J. Clin. Pharmacol. 2000; 49: 580–590.

9. Hsit J.A., Silverstein M.D., Mohr D.N. et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch. Intern. Med. 2000; 160: 809–815.

10. Oger E. Incidence of venous thromboembolism: a commu- nity-based study in Western France. Thromb Haemost 2000; 83: 657–660.

11. Bernstein C.N., Blanchard J.F., Houston D.S. et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel dis- ease, a population-based cohort sludy. Thromb. Haemost. 2001; 85: 430–43.

12. Danilenko-Dixon D.R., Heit J.A., Silverstein M.D. et al. Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post parlum: a population- based, case-control study. Am. J. Obstetr. Gynecol. 2001; 184: 104–110.

13. Heit J.A., Silverslein M.D., Mohr D.N. The epidemiology of venous thromboembolism in the community. Thromb. Haemost. 2001; 86: 452–463.

14. Golin V., Sprovieri S.R., Bedrikow R. et al. Pulmonary thromboembolism: retrospective study of necropsies performed over 24 years in a university hospital in Brazil. Sao Paulo Med. J. 2002; 120: 105–108.

15. Tveit D.P., Hypolite I.O., Hshieh P. et al. Chronic dialysis patients have high risk for pulmonary embolism. Am. J. Kidney Dis. 2002; 39; 1011–1017.

16. Tsai A.W., Cushman M., Rosamond W.D. et al Cardio- vascular risk factors and venous thromboembolism inci- dence: the longitudinal investigation of thromboembolism etiology. Arch. Intern. Med. 2002; 162: 1182–1189.

17. Khon A., Emberson J., Dowd G.S. Standardized mortality ratios and fatal pulmonary embolism rates following total knee replacement: a cohort of 936 consecutive cases. J. Knee Surg. 2002; 15: 219–222.

18. Hirsh J., O'Donnell M.J. Venous thromboembolism after long flights: are airlines to blame? Lancet 2001; 357; 1461–1462.

19. Ferrari E., Chevallier T., Chapclier A. et al. Travel as risk factor for venous thromboembolic disease: a case-control sludy. Chest 1999; 115: 440–444.

20. Samoma M.M. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch. Intern. Med. 2000; 160: 3415–3420.

21. Uspostolle F., Surget V., Borron S.W. et al. Severe pul- monary embolism associated with air travel. N. Engl. J. Med. 2001; 345: 779–783.

22. Scurr J.H., Machin S.J., Bailey-King S. et al. Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial. Lancet 2001; 357: 1485–1489.

23. Oger E., Scarabin P.Y. Assessment of the risk for venous thromboembolism among users of hormone replacement therapy. Drugs Aging 1999; 14: 55–61.

24. Anonymous. Oral contraceptives and cardiovascular risk. Drug Ther Bull 2000; 38: 1–5.

25. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of oestrogen plus progestin in heallhy postmenopausal women. J.A.M.A. 2002; 288: 321–323.

26. Kemmeren J.M., Algra A., Grobbee D.E. Third generation oral contraceptives and risk of venous thrombosis: metaanalysis. Br. Med. J. 2001; 323: 131–139.

27. Lidegaard O., Edslrom B., Kreiner S. Oral contraceptives and venous thromboembolism: a five-year national case-control study. Contraception 2002; 65: 187–196.

28. McColl M.D., Ramsay J.E., Tait R.C. et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 1997; 78: 1183–1188.

29. Gherman R.B., Goodwin T.M., Leung B. et al. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstetr and Gynecol 1999; 94: 730–734.

30. Ros H.S., Lichtenstein P., Bellacco R. et al. Pulmonary embolism and stroke in relation to pregnancy: how can high-risk women be identified? Am. J. Obstetr. Gynecol. 2002; 136: 198–203.

31. Greaves M. Thrombophilia Clin. Med. 2001; 1: 432–435.

32. Seiigsohn U., Lubetsky A. Genetic susceptibility to venous thrombosis. N. Engl. J. Med. 2001; 344: 1222–1231.

33. Folsom A.R., Aleksic N., Wang L. et al. Protein C, antithrombin, and venous thromboembolism incidence: a prospective population-based study. Arterios. Cler. Thromb. Vasc. Biol. 2002; 22: 1018–1022.

34. Martinelli I., De Stefano V., Taioli E. et al. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Thromb. Haemost. 2002; 87: 791–795.

35. Kearon C., Gent M., Hirsh J. et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N. Engl. J. Med. 1999; 340: 901–907.

36. De Stefano V., Martinelh I., Mannucci P.M. et al. The risk of recurrent venous ihromboembolism among heterozy- gous carriers of the G20210A prothrombin gene mutation. Br. J. Haematol. 2001; 113: 630–635.

37. Eichinger S., Weltermann A., Monnhalter C. et al. The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism. Arch. Intern. Med. 2002; 162: 2357–2360.

38. Greaves M., Baglin T. Laboratory testing for heritable thrombophilia: impact on clinical management of throm- botic disease. Br. J. Haematol. 2000: 109: 699–703.

39. British Committee for Standards in Haematology Investigation and management of heritable thrombophilia. Br. J. Haematol. 2001; 114: 512–528.

40. Gran E., Real E., Medrano J. et al. Recurrent venous thromboembolism in a Spanish population: incidence, risk factors, and management in hospital setting. Thromb. Res. 1999; 96; 335–341.

41. Prondoni P., Lensing A., Buller H. et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N. Engl. J. Med. 1992; 327: 1128–1133.

42. Monreal M., Casals A., Boix J. et al. Occult cancer in patients with acute pulmonary embolism. A prospective study. Chest 1993, 103:816–819.

43. Bastounis E.A., Karayiannakis A.J., Makri G.G. et al. The incidence of occult cancer in patients with deep venous thrombosis, a prospective study. J. Intern. Med. 1996; 239: 153–156.

44. Baron J.A., Gridley G., Weiderpass E., et al. Venous throm- boembolism and cancer. Lancet 1998; 351: 1077–1080.

45. Sorensen H.T., Mellemkjaer L., Steffensen F.H. et al. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N. Engl. J. Med. 1998; 338; 1169–1173.

46. Cornuz J., Pearson S.B., Creager M.A. et al. Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis. Ann. Intern. Med. 1996; 125: 785–793.

47. Hettiarachchi R.J., Lok J., Prins M.H. et al. Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis. Cancer 1998; 83: 180–185.

48. Sorensen H.T., Mellemkjaer L., Olsen J.H. et al. Prognosis of cancers associated with venous thromboembolism. N. Engl. Med. 2000; 343: 1846–1850.

49. Joung S., Robinson B. Venous thromboembolism in cancer patients in Christchurch, 1995–1999. N.Z. Med. J. 2002; 115: 257–260.

50. Heit J.A., Mellon I.J., Lohse C.M. et al. Incidence of venous thromboembolism in hospitalised patients vs community residents. Mayo Clin. Proc. 2001; 76: 1102–1110.

51. Heit J.A., O'Fallon W.M., Petterson T.M. et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: о population-based study. Arch. Intern. Med. 2002; 162: 1245–1248.

52. Ferrari E., Baudouy M., Cerboni P. et al. Clinical epidemiology of venous thromboembolic disease. Results of a French Multicentre Registry. Eur. Heart. J. 1997; 18: 685–691.

53. Kasper W., Konstantinides S., Geibel A. et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J. Am. Coll. Cardiol. 1997; 30: 1165–1171.

54. Goldhaber S.Z., Visani L., De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386–1389.

55. Nakamura M., Fujioka H., Yamada N. et al. Clinical characterises of acute pulmonary thromboembolism in Japan: results of a multiccnter registry in the Japanese Society of Pulmonary Embolism Research. Clin. Cardiol. 2001; 24: 132–138.

56. Janata K., Holzer M., Domanovits H. et al. Mortality of patients with pulmonary embolism. Wien. Klin. Wschr. 2002; 14: 766–772.

57. Heit J.A., Silverslein M.D., Mohr D.N. et al. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch. Intern. Med. 1999; 159: 445–453.

58. Wicki J., Perrier A., Perneger T. et al. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb. Haemost. 2000; 84: 548–552.

59. Heit J.A., Mohr D.N., Silverstein M.D. et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch. Intern. Med. 2000; 160: 761–768.

60. Ferrari E., Imbert A., Chevalier T. et al. The ECG in pulmonary embolism. Predictive value of negative T waves in precordial leads: 80 case reports. Chest 1997; 111: 537–543.

61. Jones J.S., Neff T.L., Carlson S.A. Use of the alveolar-arterial oxygen gradient in the assessment of acute pulmonary embolism. Am. J. Emerg. Med. 1998; 16: 333–337.

62. Afzal A., Noor H.A., Gill S.A. et al. Leukocytosis in acute pulmonary embolism. Chest 1999; 115: 1329–1332.

63. Prediletto R., Miniati M., Tonelli L. et al. Diagnostic value of gas exchange tests in patients with clinical suspicion of pulmonary embolism. Crit. Care 1999; 3: 111–116.

64. Elliott C.G., Goldhaber S.Z., Visani L., et al. Chest radiographs in acute pulmonary embolism. Results from the International Cooperative Pulmonary Embolism Registry. Chest 2000; 118:33–38.

65. Rodger M., Carrier M., Jones G., et al. Diagnostic value of arterial blood gas measurement in suspected pulmonary embolism. Am. J. Respir. Crit. Care Med. 2000; 162: 2105–2108.

66. Rodger M., Makropoulos D., Turek M., et al. Diagnostic value of the electrocardiogram in suspected pulmonary embolism. Am. J. Cardiol 2000; 86: 807–809.

67. Stein P.D., Afzal A., Henry J.W. et al. Fever in acute pulmonary embolism. Chest 2000; 117: 39–42.

68. Daniel K.R., Courtney D.M., Kline J.A. Assessment of cardiac stress from massive pulmonary embolism with 12-lead ECG. Chest 2001; 120: 474–481.

69. Petrov D.B. Appearance of right bundle branch block in electrocardiograms of patients with pulmonary embolism as a marker for obstruction of the main pulmonary trunk. J. Electrocardiol. 2001; 34: 185–188.

70. Ullman E., Brady W.J., Perron A.D. et al. Electrocordiographic manifestations of pulmonary embolism. Am. J. Emerg. Med. 2001: 19: 514–519.

71. Girard P., Decousus M., Laporte S. et al. Diagnosis of pulmonary embolism in patients with proximal deep vein thrombosis: specificity of symptoms and perfusion defects at baseline and during anticoagulant therapy. Am. J. Respir. Crit. Care Med. 2001; 164: 1033–1037.

72. Pacouret G., Schellenberg F., Hamel E. et al. Troponin I in massive acute pulmonary embolism: results of a prospective series (French). Presse Med. 1998; 27: 1627.

73. Peetz D., Post F., Voigtlander T. et al. Troponin I as a marker of right ventricular overload in acute pulmonary embolism (German). Lab. Med. 1998; 22: 553–558.

74. Giannitsis E., Muller-Bardorff M., Kurowski V. et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102: 211–217.

75. Meyer T., Binder L., Hruska N. et al. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J. Am. Coll. Cardiol. 2000; 36: 1632–1636.

76. Douketis J.D. Elevated cardiac troponin levels in patients with submassive pulmonary embolism. Arch. Intern. Med. 2002; 162: 79–81.

77. Konstantinides S., Geibel A., Olschewski M. et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002; 106: 1263–1268.

78. Janata K., Holzer M., Laggner A.N. et al. Cardiac troponin T in the severity assessment of patients with pulmonary embolism: cohort study. Br.Med.J. 2003; 326: 312–313.

79. Iwadate K., Tanno K., Doi M. et al. Two cases of right ventricular ischemic injury due to massive pulmonary embolism. Forens. Sci. Int. 2001; 116: 189–195.

80. Tverskaya M.S., Karpova V.V., Virganskii А.О. et al. Structural and metabolic changes in cardiac conducting system during massive pulmonary embolism. Bull. Exp. Biol. Med. 2001; 130: 940–944.

81. Dieter R.S., Ernst E., Ende D.J. et al. Diagnostic utility of cardiac troponin-levels in patients with suspected pulmonary embolism. Angiology 2002; 53: 583–585.

82. Sanson B.J., Lijmer J.G., MacGillavry M.R. et al. Comparison of a clinical probability estimate and two clinical models in patients with suspected pulmonary embolism. Thromb. Haemost. 2000; 83: 199–203.

83. Leclercq M.G., Lutisan J.G., van Marwijk Kooy M. et al. Ruling out clinically suspected pulmonary embolism by assessment of clinical probability and D-dimer levels: a management study. Thromb. Haemost. 2003; 89: 97–103.

84. Wells P.S., Ginsberg J.S., Anderson D.R. et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann. Intern. Med. 1998; 129: 997–1005.

85. Miniati M., Prediletto R., Formichi B. et al. Accuracy of clinical assessment in the diagnosis of pulmonary embolism. Am. J. Respir. Crit. Care Med. 1999; 159: 864–871.

86. Perrier A., Miron M.J., Desmarais S. et al. Using clinical evaluation and lung scan to rule out suspected pulmonary embolism: is it a valid option in patients with normal results of lower-limb venous compression ultrasonography? Arch. Intern. Med. 2000; 160: 512–516.

87. Righini M., Goehring C., Bounameaux H. et al. Effects of age on the performance of common diagnostic tests for pulmonary embolism. Am. J. Med. 2000; 109: 357–361.

88. Lukaschek J., Schmid H.R., Vorburger C. et al. Critical appraisal of the diagnostics of 270 consecutive cases of suspected venous thromboembolism and established consequences at a non-university centre. Swiss. Med. Week. 2001; 131: 653–658.

89. Wicki J., Perneger T.V., Junod A.F. et al. Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score. Arch. Intern. Med. 2001: 161: 92–97.

90. Chagnon I., Bounameaux H., Aujesky D. et al Comparison of two clinical prediction rules and implicit assessment among patients with suspected pulmonory embolism. Am. J. Med. 2002; 113: 269–275.

91. Musset D., Parent F., Meyer G. et al. Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study. Lancet 2002; 360: 1914–1920.

92. Rosen M., Sands D., Morris J. et al. Does a physician's ability to accurately assess the likelihood of pulmonary embolism increase with training? Acad. Med. 2000; 75: 1199–1205.

93. Wells P.S., Anderson D.R., Rodger M. et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb. Haemost. 2000; 83: 416–420.

94. Wells P.S., Anderson D.R., Rodger M. et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer. Ann. Intern. Med. 2001; 135: 98–107.

95. Bova C., Greco F., Ferrari A. et al. The usefulness of the association of clinical probability, rapid plasma measurement of D-dimer, compression echography of the lower limbs and echocardiograpby in the diagnosis of acute pulmonory embolism (Italian). Ital. Heart. J. 2000; 1: 116–121.

96. Campo J.F., Hernandez M.J., Anta M. et al. Concordance in the clinical diagnosis of pulmonary embolism (Spanish). Med. Clin. (Barc.) 1998; 111: 121–124.

97. Egermayer P., Town G.L., Turner J.G. et al. Usefulness of D-dimer, blood gas, and respiratory rate measurements for excluding pulmonary embolism. Thorax 1998; 53: 830–834.

98. Kline J.A., Nelson R.D., Jackson R.E. et al. Criteria for the safe use of D-dimer testing in emergency department patients with suspected pulmonary embolism, a multicenter US study. Ann. Emerg. Med. 2002; 39: 144–152.

99. Miron M.J., Perrier A., Bounameaux H. et al. Contribution of noninvasive evaluation to the diagnosis of pulmonory embolism in hospitalised patients. Eur. Respir. J. 1999; 13: 1365–1370.

100. Ghirardini G., Battioni M., Bertellini C. et al. D-dimer after delivery in uncomplicated pregnancies. Clin. Exp. Obstetr. Gynecol. 1999; 26: 211–212.

101. De Monye W., Sanson B.J., MacGillavry M.R. et al. Embolus location affects the sensitivity of a rapid quantitative D-dimer assay in the diagnosis of pulmonary embolism. Am. J. Respir. Crit. Care Med. 2002; 165: 345–348.

102. Kline J.A., Johns K.L., Colucciello S.A. et al. New diagnostic tests for pulmonary embolism. Ann. Emerg. Med. 2000; 35: 168–180.

103. Ginsberg J.S., Wells P.S., Kearon C. et al. Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism. Ann. Intern. Med. 1998; 129: 1006–1011.

104. MacGillavry M.R., Lijmer J.G., Sanson B.J. et al. Diagnostic accuracy of triage tests to exclude pulmonary embolism. Thromb. Haemost. 2001; 85: 995–998.

105. Chunilal S.D., Brill-Edwards P.A., Stevens P.B. et al. The sensitivity and specificity of a red blood cell agglutination D-dimer assay for venous thromboembolism when performed on venous blood. Arch. Intern. Med. 2002; 162: 217–220.

106. Perrier A., Desmarais S., Miron M.J. et al. Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet 1999; 353: 190–195.

107. Freyburger G., Trillaud H., Labrouche S. et al. D-dimer strategy in thrombosis exclusion: a gold standard study in 100 patients suspected of deep venous thrombosis or pulmonary embolism. Thromb. Haemost. 1998; 79: 32–37.

108. Anderson D., Wells P. D-dimer for the diagnosis of venous thromboembolism. Curr. Opin. Hematol. 2000; 7: 296–301.

109. Pacouret G. Association between D-dimer and helical CT scanning in the diagnosis of pulmonary embolism: a prospective study of 106 ambulatory patients (French). Presse Med. 2002; 31: 13–18.

110. Bates S.M., Grand Maison A., Johnston M. et al. A latex D-dimer reliably excludes venous thromboembolism. Arch. Intern. Med. 2001; 161: 447–453.

111. Kovacs M.J., MacKinnon K.M., Anderson D. et al. A comparison of three rapid D-dimer methods for the diagnosis of venous thromboembolism. Br. J. Haematol. 2001; 115: 140–144.

112. Reber G., Bounameaux H., Perrier A. et al. Performances of a new, automated latex assay for the exclusion of venous thromboembolism. Blood Coag. Fibrinol. 2001; 12: 217–220.

113. Burkill G.J., Bell J.R., Chinn R.J. et al. The use of a D-dimer assay in patients undergoing CT pulmonary angiography for suspected pulmonary embolus. Clin. Radiol. 2002; 57: 41–46.

114. Palareti G., Legnani C., Cosmi B. et al. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thromb. Haemost. 2002; 87: 7–12.

115. Nilsson T., Mare K., Carlsson A. Value of structured clinical and scintigraphic protocols in acute pulmonary embolism. J. Intern. Med. 2001; 250: 213–218.

116. Prologo J.D., Glauser J. Variable diagnostic approach to suspected pulmonary embolism in the ED of a major academic tertiary care center. Am. J. Emerg. Med. 2002; 20: 5–9.

117. Lemb M., Pohlabeln H. Pulmonary thromboembolism: a retrospective study on the examination of 991 patients by ventilation / perfusion SPECT using Technegas. Nucl. Med. 2001; 40: 179–186.

118. Gottschalk A. New criteria for ventilation-perfusion lung scan interpretation: a basis for optimal interaction with helical CT angiography. Radiographics 2000; 1206–1210.

119. Itti E., Nguyen S., Robin F. et al. Distribution of ventilation / perfusion ratios in pulmonary embolism: an adjunct to the interpretation of ventilation / perfusion lung scans. J. Nucl. Med. 2002; 43: 1596–1602.

120. Worsley D.F., Alavi A. Radionuclide imaging of acute pulmonary embolism. Radiol. CIin. N. Am. 2001; 39: 1035–1052.

121. Burkill G.J., Bell J.R., Padley S.P. Survey on the use of pulmonary scintigraphy, spiral CT and conventional pulmonary angiography for suspected pulmonary embolism in the British Isles. Clin. Radiol. 1999; 54: 807–810.

122. Hagen P.J., van Strijen M.J., Kieft G.J. et al. The application of a Dutch consensus diagnostic strategy for pulmonary embolism in clinical practice. Neth J. Med. 2001; 59: 161–169.

123. Chan W.L., McLean R., Carolan M.G. What happens after a lung scan? Management and outcome of patients in a regional hospital. Australas. Radiol. 2002; 46: 375–380.

124. Khorasani R., Gudas T.F., Nikpoor N. et al. Treatment of patients with suspected pulmonary embolism and intermediate-probability lung scans: is diagnostic imaging underused? Am. J. Roentgenol. 1997; 169: 1355–1357.

125. Kuijer P.M., Turkstra F., van Beek E.J. et al. A survey of the diagnostic and therapeutic management of patients with suspected pulmonary embolism in the Netherlands. Neth.J. Med 1997; 50: 261–266.

126. Broekhuizen-de Gast H.S., Tiel-van Buul M.M., Ubbink M. et al. The value of the 'non-diagnostic' lung scan — further classification as to the risk of pulmonary embolism is not reliable (Dutch). Ned. Tijdschr. Geneesk. 2000; 144: 1537–1542.

127. Rosen M.P., Sands D.Z., Kuntz K.M. Physicians' attitudes toward misdiagnosis of pulmonary embolism: a utility analysis. Acad. Radiol. 2000; 7: 14–20.

128. Walsh G., Jones D.N. Subsequent investigation and management of patients with intermediate-category and — probability ventilation-perfusion scintigraphy. Australas. Radiol. 2000: 44: 424–427.

129. Berghout A., Oudkerk M., Hicks S.G. et al. Active implementation of a consensus strategy improves diagnosis and management in suspected pulmonary embolism. Quart. J. Med. 2000; 93: 335–340.

130. Gray H.W., Bessent R.G., McKillop J.H. A preliminary evaluation of diagnostic odds in lung scan reporting. Nucl. Med. Commun. 1993; 19: 113–118.

131. Rajendran J.G., Jacobson A.F. Review of 6-month mortality following low-probability lung scans. Arch. Intern. Med. 1999; 159: 349–352.

132. Van Beek E.J.R., Brouwers E.M.J., Song B. et al. Lung scintigraphy and helical computed tomography for the diagnosis or pulmonary embolism: a meta-analysis. Clin. Appl. Thromb. Hemost. 2001; 7: 87–92.

133. Hartmann I., Hagen P., Melissant C. et al. Diagnosing acute pulmonary embolism: effect of chronic obstructive pulmonary disease on the performance of D-dimer testing, ventilation / perfusion scintigraphy, spiral computed tomographic angiography, and conventional angiography. Am. J. Respir. Crit. Care Med. 2000; 162: 2232–2237.

134. Infante J.R., Torres-Avisbal M., Gonzales F.M. et al. Effect of different observers on the interpretation of pulmonary perfusion scintigraphy (Spanish). Rev. Esp. Med. Nucl. 2002; 21: 93–98.

135. Forbes K.P., Reid J.H., Murchison J.T. Do preliminary chest X-ray findings define the optimum role of pulmonary scintigraphy in suspected pulmonary embolism? Clin. Radiol. 2001; 56: 397–400.

136. Wilson H.T., Meagher T.M., Williams S.J. Combined helical computed tomographic pulmonary angiography and lung perfusion scintigraphy for investigating acute pulmonary embolism. Clin. Radiol. 2002; 57: 33–36.

137. British Nuclear Medicine Society. Quality guidelines for ventilation / perfusion imaging for pulmonary embolic disease, http://www.bnms.org.uk/bnms.htm; 2001.

138. Bastuji-Garin S., Schaeffer A., Wolkenstein P. et al. Pulmonary embolism, lung scanning interpretation: about words. Chest 1998; 114: 1551–1555.

139. Gray H.W., Neilly J.B. The role and vaIue of ventilation perfusion imaging in pulmonary embolism. In: Oudkerk M., van Beek E.J.R., ten Cate J.W., eds. Pulmonary embolism: epidemiology, diagnosis and treatment. Oxford. Blackwell Science, 1999; 84–123.

140. Clarke S.E.M., Burwood R., Сох С. Reaudit lung scintigraphy: ventilation and perfusion imaging for the investigation of possible acute pulmonary embolism. London. South Thames Region Nuclear Medicine Audit Group; 2001.

141. Turkstra F., Kuijer P.M., van Beek E.J. et al. Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann. Intern. Med. 1997; 126: 775–781.

142. Torres J.A., Aracil E., Puros E. et al.Role of venous duplex imaging of lower extremity for pulmonary embolism diagnostic. Angiologia 1999; 51: 71–76.

143. MacGillavry M., Sanson B., Buller H. et al. Compression ultrasonography of the leg veins in patients with clinically suspected pulmonary embolism: is a more extensive assessment of compressibility useful? Thromb. Haemost. 2000; 84: 973–976.

144. Barrellier M., Lezin B., Landy S. et al. Prevalence of duplex ultrasonography detectable venous thrombosis in patients with suspected or acute pulmonary embolism. J. Mal. Vasc 2001; 26: 23–30.

145. Girard P., Musset D., Parent F. et al. High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism. Chest 1999; 116: 903–908.

146. Daniel K.R., Jackson R.E., Kline J.A. Utility of lower extremity venous ultrasound scanning in the diagnosis and exclusion of pulmonary embolism in outpatients. Ann. Emerg. Med. 2000; 35: 547–554.

147. Meyerovitz M.F., Mannting F., Polak J.F. et al. Frequency of pulmonary embolism in patients with low-probability lung scan and negative lower extremity venous ultrasound. Chest 1999; 115: 980–982.

148. Elias A., Mallard L., Elias M. et al. A single complete ultrasound investigation of the venous network for the diagnostic management of patients with a clinically suspected first episode of deep venous thrombosis of the lower limbs. Thromb. Haemost. 2003; 289: 22–227.

149. Hull R.D., Raskob G.E., Ginsberg J.S. et al. A noninvasive strategy for the treatment of patients with suspected pulmonary embolism. Arch. Intern. Med. 1994; 154: 289–297.

150. Wells P.S., Ginsberg J.S., Anderson D.R. et al. Utility of ultrasound imaging of the lower extremities in the diagnostic approach in patients with suspected pulmonary embolism. J. Intern. Med. 2001; 250: 262–264.

151. Diffin D.C., Leyendecker J.R., Johnson S.P. et al. Effect of anatomic distribution of pulmonary emboli on interobserver agreement in the interpretation of pulmonary angiography. Am. J. Roentgenol. 1998; 171: 1085–1089.

152. Baile E.M., King G.G., Muller N.L. et al. Spiral computed tomography is comparable to angiography for the diagnosis of pulmonary embolism. Am. J. Respir. Crit. Care Med. 2000; 161: 1010–1015.

153. Van Rossum A.B., Bongaerts А.Н.Н., Woodard P.K. Helical computed tomography and pulmonary embolism. In: Oudkerk M.B.E., ten Cate J.W., eds. Pulmonary embolism: epidemiology, diagnosis and treatment. Oxford: Blackwell Science; 1999:192–225.

154. Remy-Jardin M., Remy J., Mayo J.R. et al. Acute pulmonary embolism. In: CT angiography of the chest. Philadelphia: Lippincott Williams & Wilkins, 2001: 51–66.

155. Mayo J.R., Remy-Jardin M., Muller N.L. et al. Pulmonary embolism: prospective comparison of spiral CT with ventilation-perfusion scintigraphy. Radiology 1997; 205: 447–452.

156. Garg K., Welsh C.H., Feyerabend A.J. et al. Pulmonary embolism:diagnosis with spiral CT and ventilation-perfusion scanning — correlation with pulmonory angiographic results or clinical outcome. Radiology 1998; 208: 201–208.

157. Van Rossum A.B., Pattynama P.M., Mallens W.M. et al. Can helical CT replace scintigraphy in the diagnostic process in suspected pulmonary embolism? A retrolective-prolective cohorl study focusing on total diagnostic yield. Eur. Radiol. 1998; 8: 90–96.

158. Blachere H., Latrabe V., Montaudon M. et al. Pulmonary embolism revealed on helical CT angiography: comparison with ventilation-perfusion radionuclide lung scanning. Am. J. Roentgenol. 2000; 174: 1041–1047.

159. Cueto S.M., Cavanaugh S.H., Benenson R.S. et al. Computed tomography scan versus venlilation-perfusion lung scan in the detection of pulmonary embolism. J. Emerg. Med. 2001; 21: 155–164.

160. Bankier A.A., Janata K., Fleischmann D., et al. Seventy assessment of acute pulmonary embolism with spiral CT: evaluation of two modified angiographic scores and comparison with clinical data.J. Thorac. Imag. 1997; 12: 150–158.

161. Mastora I., Remy-Jardin M., Masson P. et al. Severity of acute pulmonary embolism: evaluation of a new spiral CT angiographic score in correlation with echocardiographic data. Eur. Radiol. 2003; 13: 29–35.

162. Van Rossum A.B., van Erkel A.R., van Persijn van Meerten E.L. et al. Accuracy of helical CT for acute pulmonary embolism: ROC analysis of observer performance related to clinical experience. Eur Radiol 1998; 8: 1160–1164.

163. Chartrand-Lefebvre C., Howarth N., Lucidarme O. et al. Contrast-enhanced helical CT for pulmonary embolism detection: inter- and intra-observer agreement among radiologists with variable experience. Am. J. Roentgenol 1999; 172: 107–112.

164. Domingo M.L., Marti-Bonmati L., Dosda R. et al. Interobserver agreement in the diagnosis of pulmonary embolism with helical CT. Eur. J. Radiol. 2000; 34: 136–140.

165. Remy-Jardin M., Remy J., Baghaie F., et al. Clinical value of thin collimation in the diagnostic workup of pulmonary embolism. Am. J. Roentgenol. 2000; 175: 407–411.

166. Perrier A., Howarth N., Didier D. et al. Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism. Ann. Intern. Med. 2001; 135: 88–97.

167. Qanadli S.D., El Hajjam M., Vieillard-Baron A. et al. New CT index to quantify arterial obstruction in pulmonary embolism: comparison with angiographic index and echocardiography. Am. J. Roentgenol. 2001; 176: 1415–1420.

168. Bourriot K., Couffinhall T., Bernard V, et al. Clinical out-come after a negative spiral CT pulmonary angiogram in an in-patient population from cardiology and pneumology wards. Chest 2003; 123: 359–365.

169. Mullins M.D., Becker D.M., Hagspiel K.D. et al. The role of spiral volumetric computed tomography in the diagnosis of pulmonary embolism. Arch. Intern. Med. 2000; 160: 293–298.

170. Rathbun S.W., Raskob G.E., Whitsett T.L. Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review. Ann. Intern. Med. 2000; 132: 227–232.

171. Safriel.Y., Zinn H. CT pulmonary angiography in the detection of pulmonary emboli: a meta-analysis of sensitivities and specificities. Clin. Imag. 2002; 26: 101–105.

172. Harvey R., Gefter W., Hrung J. et al. Accuracy of CT angiography versus pulmonary angiography in the diagnosis of acute pulmonary embolism: evaluation of the literature with summary ROC curve analysis. Acad. Radiol. 2000; 7: 786–797.

173. Remy-Jardin M., Remy J., Artaud D. et al. Spiral CT of pulmonary embolism, diagnostic approach, interpretive pitfalls and current indications. Eur. Radiol. 1998; 8: 1376–1390.

174. Howling S.J., Hansell D.M. Spiral computed tomography for pulmonary embolism. Hosp. Med. 2000; 61: 4l–45.

175. Stein P.D., Henry J.W. Prevalence of acute pulmonary embolism in central and subsegmental pulmonary arteries and relation to probability interpretation of venlilation/perfusion lung scans. Chest 1997; 111: 1246–1248.

176. Qanadli S., Hajjam M., Mesurolle B. et al. Pulmonary embolism detection: prospective evaluation of dual-section helical CT versus selective pulmonary arteriography in 157 patients. Radiology 2000; 217: 447–455.

177. Remy-Jardin M, Tillie-Leblond I., Szapiro D, et al. CT angiography of pulmonary embolisrn in patients with underlying respiratory disease: impact of multi-slice CT (MSCT] on image quality and negative predictive value. Eur. Radiol. 2002; 12: 1971–1978.

178. De Monye W., van Strijen M.J., Huisman M.V. et al. Suspected pulmonary embolism: prevalence and anatomic distribution in 487 consecutive patients. Radiology 2000; 215: 184–188.

179. Raptopoulos V., Boiselle P.M. Multi-detector row spiral CT pulmonary angiography: comparison with single-detector row spiral CT. Radiology 2001: 221: 606–613.

180. Schoepf U.J., Holzknecht N., Helmberger T.K. et al. Subsegmental pulmonary emboli: improved detection with thin-collimation multi-detector row spiral CT. Radiology 2002; 222: 483–490.

181. Reid J.H., Murchison J.T. Acute right ventricular dilatation; a new helical CT sign of massive pulmonary embolism. Clin. Radiol. 1998; 53: 694–698.

182. Wintersperger B.J., Stabler A., Seemann M. et al. Evaluation of right ventricular performance in patients with acute pulmonary embolism by helical CT (German). Rofo Fortschr. 1999; 170: 542–549.

183. Ferretti G.R., Bosson J.L., Buffaz P.D. et al. Acute pulmonary embolism: role of helical CT in 164 patients with intermediate probability at ventilation-perfusion scintigraphy and normal results at duplex US of the legs. Radiology 1997; 205: 453–458.

184. Garg K., Sieler H., Welsh C.H. et al. Clinical validity of helical CT being interpreted as negative for pulmonary embolism: implications for patient treatment. Am. J. Roentgenol. 1999; 172: 627–631.

185. Lomis N.N., Yoon H.C., Moran A.G. et al. Clinical out-comes of patients after a negative spiral CT pulmonary arteriogram in the evaluation of acute pulmonary embolism. J. Vasc. Intervent. Radiol. 1999; 10: 707–712.

186. Lorut C., Ghossains M., Horellou M. et al. A non-invasive diagnostic strategy including spiral computed tomography in patients with suspected pulmonary embolism. Am. J. Respir. Crit. Care Med. 2000; 162: 1413–1418.

187. Goodman L.R., Lipchik R.J., Kuzo R.S. et al. Subsequent pulmonary embolism risk after a negative helical CT pulmonary angiogram; prospective comparison with scintigraphy. Radiology 2000; 215: 535–542.

188. Gottsater A., Berg A., Centergard J. et al. Clinically suspected pulmonary embolism: is it safe to withhold anticoagulation after a negative spiral CT? Eur. Radiol. 2001; 11: 65–72.

189. Nilsson T., Olausson A., Johnsson H. et al. Negative spiral CT in acute pulmonary embolism. Acta Radiol 2002; 43: 486–491.

190. Novelline R.A., Baltarowich O.H., Athanosoulis C.A. et al. The clinical course of patients with suspected pulmonary embolism and a negative pulmonary arteriogram. Radiology 1978; 126: 561–567.

191. Cheely R., McCartney W.H., Perry J.R. et al. The role of noninvasive tests versus pulmonary angiography in the diagnosis of pulmonary embolism. Am. J. Med. 1981; 70: 17–22.

192. Henry J.W., Relyea B., Stein P.D. Continuing risk of thromboemboli among patients with normal pulmonary angiograms. Chest 1995; 107: 1375–1378.

193. Von Beek E.J., Kuijer P.M., Bulier H.R. et al. The clinical course of patients with suspected pulmonary embolism. Arch. Intern. Med. 1997; 157: 2593–2598.

194. Swensen S.J., Sheedy P.F., Ryu J.H. et al. Outcomes after withholding anticoagulalion from patients with suspected acute pulmonary embolism and a negative computed tomogram: a cohort study. Mayo Clin. Proc. 2002; 77: 130–138.

195. Ginsberg M.S., Oh J., Welber A. et al. Clinical usefulness of imaging performed after CT angiography that was negative for pulmonary embolus in a high-risk oncologic population. Am. J. Roentgenol. 2002; 179: 1205–1208.

196. Cham M.D., Yankelevitz D.F., Shaham D. et al. Deep venous thrombosis: detection by using indirect CT venography. The Pulmonary Angiography-lndirect CT Venog- raphy Cooperative Group. Radiology 2000; 216: 744–751.

197. Duwe K., Shiau M., Budorick N., et al. Evaluation of the lower extremity veins in patients wilh suspected pulmonary embolism: a retrospective comparison of helical CT venography and sonography. Am. J. Roentgenol. 2000; 173: 1525–1531.

198. Garg K., Kemp J.L., Wojcik D. et al. Thromboembolic disease: comparison of combined CT pulmonary angiography and venography with bilateral leg sonography in 70 patients. Am. J. Roentgenol. 2000; 175: 997–1001.

199. Ghaye B., Szapiro D., Willems V. et al. Combined CT venography of the lower limbs and spiral CT angiography of pulmonary arteries in acute pulmonary embolism: preliminary results of a prospective study. J. Belg. Radiol. 2000; 83: 271–278.

200. Аu V.W., Walsh G., Fon G. Computed tomography pulmonary angiography with pelvic venography in ihe evaluation of thrombo-embolic disease. Australas. Radiol. 2001; 45: 141–145.

201. Loud P.A., Katz D.S., Bruce D.A. et al. Deep venous thrombosis with suspected pulmonary embolism: detection with combined CT venography and pulmonary angiography. Radiology 2001; 219: 498–502.

202. Nicolas M., Debeile L., Laurent V. et al. Incremental lower extremity CT venography, a simplified approach for the diagnosis of deep venous thrombosis in patients with pulmonary embolism. J Radiol 2001; 82: 251–256.

203. Peterson D.A., Kazerooni E.A., Wakefield T.W. et al. Computed tomographic venography is specific but not sensitive for diagnosis of acute lower-extremity deep venous thrombosis in patients with suspected pulmonary embolus. J. Vasc. Surg. 2001; 34: 798–804.

204. Wildberger J.E., Mahnken A.H., Sinha A.M. et al. A differentiated approach to the diagnosis of pulmonary embolism and deep venous thrombosis using multi-slice CT (German). Rofo Fortschr. 2002; 174: 301–307.

205. Jonetz-Mentzel L., Eger C., Basche S. CT venography and CT angiography of the pulmonary arteries in acute pulmonary embolism (German). Zbl. Chir. 2002; 127: 755–759.

206. Rademaker J., Griesshaber V., Hidajat N., et al. Combined CT pulmonary angiography and venography for diagnosis of pulmonary embolism and deep vein thrombosis: radiation dose. J. Thorac. Imag. 2001; 16: 297–299.

207. Velmahos G.C., Vassiliu P., Wilcox A. et al. Spiral computed tomography for the diagnosis of pulmonary embolism in critically ill surgical patients, a comparison with pulmonary angiography. Arch. Surg. 2001; 136: 505–511.

208. Tillie-Leblond I., Mastora I., Radenne F. et al. Risk of subsequent pulmonary embolism after a negative spiral angiogram in patients with underlying pulmonary disease: a one-year clinical follow-up study. Radiology 2002; 232: 461–467.

209. Kasper W., Konstantinides S., Geibel A. et al. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart 1997; 77: 346–349.

210. Serafini O., Bisignani G., Greco F. et al. The role of 2D-Doppler electrocardiography the early diagnosis of massive acute pulmonary embolism and therapeutic monitoring (Italian). G. Ital. Cardiol. 1997; 27: 462–469.

211. Jackson R.E., Rudoni R.R., Hauser A.M. et al. Prospective evaluation of two-dimensional transthoracic echocardiography in emergency department patients with suspected pulmonary embolism. Acad. Emerg. Med. 2000; 7: 994–998.

212. Miniati M., Monti S., Pratali L. et al. Value of transthoracic echocardiography in the diagnosis of pulmonary embolism: results of a prospective study in unselected patients. Am. J. Med. 2001; 110: 528–535.

213. Vieillard-Baron A., Page B., Augarde R. et al. Acute cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate. Intensive Care Med. 2001; 27: 1481–1486.

214. Comess K., DeRook F., Russell M. et al. The incidence of pulmonary embolism in unexplained sudden cardiac arrest with pulseless electrical activity. Am. J. Med. 2000; 109: 351–356.

215. Krivec B., Voga G., Zuran I. et al. Diagnosis and treatment of shock due to massive pulmonary embolism: approach with transoesophageal echocardiography and intrapulmonary thrombolysis. Chest 1997; 112: 1310–1316.

216. Antakly-Hanon Y., Vieillard-Baron A, Qanadli S.D. et al. The value of transoesophageal echocardiography for the diagnosis of pulmonary embolism wilh acute cor pulmonale (French). Arch. Mal. Coeur. 1998; 91: 843–848.

217. Otmani A., Tribouilloy C., Leborgne L. et al. Diagnostic value of echocardiography and thoracic spiral CT angiography in the diagnosis of acute pulmonary embolism (French). Ann. Cardiol. Angeiol. 1998; 47: 707–715.

218. Pruszczyk P., Torbicki A., Kuch-Wocial A. et al. Diagnostic value of transoesophageal echocardiography in suspected haemodynamically significant pulmonary embolism. Heart 2001; 85: 628–634.

219. Mathis G., Bitschnau R., Gehmacher O., et al. Chest ultrasound in diagnosis of pulmonary embolism in comparison to helical CT. Ultraschall Med. 1999; 20: 54–59.

220. Reissig A., Heyne J.P., Kroegel C. Sonography of lung and pleura in pulmonary embolism: sonomorphologic characterisation and comparison with spiral CT scanning. Chest 2001; 120: 1977–1983.

221. Lechleitner P., Riedl B., Raneburger W. et al. Chest sonography in the diagnosis of pulmonary embolism; a comparison with MRI angiography and ventilation perfusion scintigraphy (German). Ultraschall Med. 2002; 23: 373–378.

222. Coche Е.Е., Muller N.L., Kim K.l. et al. Acute pulmonary embolism: ancillary findings at spiral CT. Radiology 1998; 207: 753–758.

223. Shah A.A., Davis S.D., Gamsu G. et al. Parenchymal and pleural findings in patients with and patients without acute pulmonary embolism detected at spiral CT. Radiology 1999; 211: 147–153.

224. Meaney J.F., Weg J.G., Chenevert T.L. et al. Diagnosis of pulmonary embolism with magnetic resonance angiography. N. Engl. J. Med. 1997; 336: 1422–1427.

225. Gupta A., Frazer C.K., Ferguson J.M. et al. Acute pulmonary embolism: diagnosis with MR angiography. Radiology 1999; 210: 353–359.

226. Bock J.C., Lehmann J. MR imaging of experimental pulmonary embolism using a macromolecular contrast medium (German). Rofo Fortschr 1997; 167: 516–520.

227. Li К.С., Pelc L.R., Napel S.A. et al. MRI of pulmonary embolism using Gd-DTPA-polyethylene glycol polymer enhanced 3D fast gradient echo technique in a canine model. Magn. Reson. Imag. 1997; 15: 543–550.

228. Hurst D.R., Kazerooni E.A., Stafford-Johnson D. et al. Diagnosis of pulmonary embolism: comparison of CT angiography and MR angiography in canines. J. Vasc. Intervent. Radiol. 1999; 10: 309–318.

229. Reittner P., Coxson H.O., Nakano Y. et al. Pulmonary embolism: comparison of gadolinium-enhanced MR angiography with contrast-enhanced spiral CT in a porcine model. Acad. Radiol. 2001; 8: 343–350.

230. Oudkerk M., van Beek E.J.R., Wielopolski P. et al. Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study. Lancet 2002; 359: 1643–1647.

231. Ong Y.E., Crowther A., Miller A. Rapid diagnosis of massive pulmonary embolism in a district general hospital. Int. J. Clin. Pract. 2000; 54: 144–146.

232. Oliver Т.В., Reid J.H., Murchison J.T. Interventricular septal shift due to massive pulmonary embolism shown by CT pulmonary angiography: an old sign revisited. Thorax 1998; 53: 1092–1094.

233. Wood K.E. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 2002; 121: 877–905.

234. Smulders Y.M. Contribution of pulmonary vasoconstriction to haemodynamic instability after acute pulmonary embolism. Implications for treatment? Neth. J. Med. 2001; 58: 241–247.

235. Daniels L.B., Parker J.A., Patel S.R. et al. Relation of duration of symptoms with response to thrombolylic therapy in pulmonary embolism. Am. J. Cardiol. 1997; 80: 184–188.

236. Arcasoy S.M., Kreit J.W. Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence. Chest 1999; 115: 1695–1707.

237. Thabut G., Thabut D., Myers R. et al. Thrombolytic therapy of pulmonary embolism: a meta-analysis. J. Am. Coll. Cardiol. 2002; 40: 1660–1667.

238. Jerjes-Sanchez C., Ramirez-Rivera A., Garcia M. de L. et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomised controlled trial. J. Thromb. Thrombolys 1995; 2: 227–229.

239. Rose P.S., Punjabi N.M., Pearse D.B. Treatment of right heart thromboemboli. Chest 2002; 121: 806–814.

240. Konstantinides S., Geibel A., Olschewski M. et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation 1997; 96: 882–888.

241. Grifoni S., Olivotto I., Cecchini P. et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 2000; 101: 2817–2822.

242. Hamel E., Pacouret G., Vincentelli D. et al.Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation: results from a 128-patient monocenter registry. Chest 2001; 120: 120–125.

243. Konstantinides S., Geibel A., Heusel G. et al. Heparin plus alteplase compared with heparin alone in palients with submassive pulmonary embolism. N. Engl. J. Med. 2002; 347: 1143–1150.

244. Serra-Prat M., Jovell A.J., Aymerich M. Efficacy and safety of thrombolytic therapy in pulmonary embolism: meta-analysis of randomised controlled trials (Spanish). Med. Clin. (Barc) 1999; 112: 685–689.

245. Agnelli G., Becattini C., Kirschstein T. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis. Arch. Intern. Med. 2002; 162: 2537–2541.

246. Gisselbrechi M., Diehl J.L, Meyer G., et al. Comparison of efficacy and tolerability of a thrombolytic treatment with rt-PA in acute massive pulmonary embolism in the elderly and patients under 75 years of age (French). Rev. Med. Interne 1997; 18: 521–527.

247. Kanter D.S., Mikkola K.M., Patel S.R. et al. Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest 1997; 111: 1241–1245.

248. Mikkola K.M., Patel S.R., Parker J.A. et al. Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis. Am. Heart J. 1997; 134: 69–72.

249. Pacouret G., Barnes S.J., Hopkins G. et al. Rapid haemodynamic improvement following saruplase in recent massive pulmonary embolism. Thromb Haemost 1998; 79; 264–267.

250. Tebbe U., Graf A., Kamke W. et al. Haemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism. Am. Heart. J. 1999; 138: 39–44.

251. Meneveau N., Schiele F., Vuillemenot A. et al. Streptokinase vs alteplase in massive pulmonary embolism. A randomised trial assessing right heart haemodynamics and pulmonary vascular obstruction. Eur. Heart J. 1997; 18: 1141–1148.

252. Meneveau N., Schiele F., Metz D. et al. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and haemodynamic outcome and one-year follow-up. J. Am. Coll. Cardiol. 1998; 31: 1057–1063.

253. Schmitz-Rode T., Kilbinger M., Gunther R.W. Simulated flow pattern in massive pulmonary embolism: significance for selective intrapulmonary thrombolysis. Cardiovasc. Intervent. Radiol. 1998; 21: 199–204.

254. Verstrate M., Miller G.A., Bounameaux H. et al. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation 1988; 77: 353–360.

255. Meyer G., Gisselbrecht M., Diehl J.L. et al. Incidence and predictors of major hemorrhagic complications from thrombolytic therapy in patienls with massive pulmonary embolism. Am. J. Med. 1998; 105: 472–477.

256. Fava M., Loyola S., Flores P. et al. Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism. J. Vasc. Intervent. Radiol. 1997; 8: 261–266.

257. Murphy J.M., Mulvihill N., Mulcahy D. et al. Percutaneous catheter and guidewire fragmentation with local administration of recombinant tissue plasminogen activator as a treatment for massive pulmonary embolism. Eur. Radiol. 1999; 9: 959–964.

258. Voigtlander T., Rupprecht H.J., Nowak B. et al. Clinical application of a new rheolytic trombectomy catheter system for massive pulmonary embolism. Catheter. Cardiovasc. Intervent. 1999; 47: 91–96.

259. Fava M., Loyola S., Huete I. Massive pulmonary embolism: treatment with the hydrolyser trombectomy catheter. J. Vasc. Intervent. Radiol. 2000; 11: 1159–1164.

260. Schmitz-Rode T., Janssens U., Duda S.H., et al. Massive pulmonary embolism; percutaneous emergency treatment by pigtail rotation catheter. J. Am. Coll. Cardiol. 2000; 36: 375–380.

261. Muller-Hulsbeck S., Brossmann J., Jahnke T. et al. Mechanical thrombectomy of major and massive pulmonary embolism with use of the Amplatz thrombectomy device. Invest. Radiol. 2001; 36: 317–322.

262. De Gregorio M.A., Gimeno M.J., Mainar A. et al. Mechanical and enzymatic thrombolysis for massive pulmonary embolism. J. Vasc. Intervent. Radiol. 2002;13: 163–169.

263. Zwaan M., Kripke N., Lorch H. et al. In-vitro evaluation of different embolectomy catheters for the treatment of acute pulmonary embolism (German). Rofo Fortschr I999; 171: 485–491.

264. Doerge H., Schoendube F.A., Voss M. et al. Surgical therapy of fulminant pulmonary embolism: early and late results. Thorac. Cardiovasc. Surg. 1999; 47: 9–13.

265. Chartier L., Michon P., Loubeyre C. et al. Mobile right heart thrombi in pulmonary embolism (French). Arch. Mal. Coeur. 1997; 90: 1471–1476.

266. Casazza F., Agostoni O., Mandelli V., et al. The cardiologist facing pulmonary embolism: the experience of 160 cases of acute cor pulmonale (Italian). Ital. Heart J. 2000; 1: 520–526.

267. Courtney D.M., Sasser H.C., Pincus C.J. et al. Pulseless electrical activity with witnessed arrest as a predictor of sudden death from massive pulmonary embolism in outpatients. Resuscitation 2001; 49: 265–272.

268. Kurkciyan I., Meron G., Sterz F. et al. Pulmonary embolism as a cause of cardiac arrest: presentation and outcome. Arch. Intern. Med. 2000; 160: 1529–1535.

269. Ruiz-Bailen M., Aguayo-de-Hoyos E., Serrano-Corcoles M.C. et al. Thrombolysis with recombinant tissue plasminogen activator during cardiopulmonary resuscitation in fulminant pulmonary embolism. A case series. Resuscitation 2001; 51: 97–101.

270. Kawahito K., Murata S., Adachi H. et al. Resuscitation and circulatory support using extra corporeal membrane oxygenation for fulminant pulmonary embolism. Artif. Organs 2000; 24: 427–430.

271. Simonneau G., Sors H., Charbonnier B. et al. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. N. Engl. J. Med. 1997; 337: 663–669.

272. Hirsh J., Warkentin Т.Е., Shaughnessy S.G. et al. Heparin and low-molecular-weight heparin mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001; 119: 64S–94S.

273. Hyers T.M., Agnelli G., Hull R.D. et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001; 119: 176S–193S.

274. Wells P.S., Kovacs M.J., Bormanis J. et al. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection. Arch. Intern. Med. 1998; 158: 1809–1812.

275. Dolovich L.R., Ginsberg J.S., Douketis J.D. et al. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch. Intern. Med. 2000; 160: 181–188.

276. Kovacs M.J., Anderson D., Morrow B. et al. Outpatient treatment of pulmonary embolism with dalteparin. Thromb. Haemost. 2000; 83: 209–211.

277. Merli G., Spiro Т.Е., Olsson C.G. et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann. Intern. Med. 2001; 134: 191–202.

278. Van den Belt A.G., Prins M.H., Lensing A.W. et al. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst. Rev. 2000; CD001 100.

279. Hull R.D., Raskob G.E., Brant R.F. et al. Low-molecularweight heparin vs heparin in the treatment of patienls with pulmonary embolism. American-Canadian Thrombosis Study Group. Arch. Intern. Med. 2000; 160: 229–236.

280. Couturaud F., Julian J.A., Kearon C. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis. Thromb. Haemost. 2001; 86: 980–984.

281. Wahlander K., Lapidus L., Olsson C-G. et al. Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thrombosis. Thromb. Res. 2002; 107: 93–99.

282. British Thoracic Society. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Lancet 1992; 340: 873–876.

283. Hirsh J. The optimal duration of anticoagulant therapy for venous thrombosis. N. Engl. J. Med. 1995; 332: 1710–1711.

284. Schulman S., Rhedin A.S., Lindmarker P. et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N. Engl. J. Med. 1995; 332: 1661–1665.

285. Agnelli G., Prandoni P., Santamaria M.G. et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. N. Engl. J. Med 2001; 345: 165–169.

286. Pinede L., Ninet J., Duhaut P. et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 2001; 103: 2453–2460.

287. Schulman S., Granqvist S., Holmstrom M. et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N. Engl.J. Med. 1997; 336: 393–398.

288. Hirsh J., Dalen J.E., Anderson D.R. et al. Oral anticoagulants, mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001; 119: 8S–21S

289. Palareti G., Leali N., Coccheri S. et al. Bleeding complications of oral anticoagulant treatment an inception-cohort, prospective collaborative study. Lancet 1996; 348: 423–428.

290. Bigaroni A., Perrier A., de Moerloose P. et al. Risk of major bleeding in unselected patients with venous thromboembolism. Blood Coagul. Fibrinolys. 2000; 11: 199–202.

291. Levine M.N., Raskob G., Landefeld S. et al. Hemorrhagic complications of anticoagulant treatment. Chest 2001; 119: 10S–21S.

292. Stein P., Hull R., Raskob G. Withholding treatmenl in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial non-invasive leg tests. Am. J. Med. 2000; 109: 301–306.

293. Oden A., Fahlen M. Oral anticoagulation and risk of death, a medical record linkage study. Br. Med. J. 2002; 325: 1073–1075.

294. Haire W.D. Vena caval filters for the prevention of pulmonary embolism. N. Engl. J. Med. 1998; 338: 463–464.

295. Decousus H., Leizorovicz A., Parent F. et al. A clinical trial of vena caval filters in the prevention of pulmonory embolism in patients with proximal deep-vein thrombosis. N. Engl. J. Med. 1998; 338: 409–415.

296. White R., Zhou H., Kim J. et al. A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism. Arch. Intern. Med. 2000; 160: 2033–2041.

297. Geffroy S., Furber A., L'Hoste P. et al. Very long term outcome of 68 vena caval filters implanted percutaneously (French). Arch. Mal. Coeur Vaiss 2002; 95: 38–44.

298. Asch M.R. Initial experience in humans with a new retrievable inferior vena cava filter. Radiology 2002; 225: 835–844.

299. Sing R.F., Jacobs D.G., Heniford В.Т. Bedside insertion of inferior vena cava filters in the intensive care unit. J. Am. Coll. Surg. 2001; 192: 570–575.

300. De Swiet M. Management of pulmonary embolus in pregnancy. Eur. Heart. J. 1999; 20: 1378–1385.

301. Ginsberg J.S., Greer I., Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001; 119: 12S–31S.

302. Greer I.A. The acute management of venous thromboembolism in pregnancy. Curr. Opin. Obstetr. Gynecol. 2001; 13: 569–575.

303. Laurent P., Dussarat G.V., Bonal J. et al. Low molecular weight heparins. a guide to their optimum use in pregnancy. Drugs 2002; 62: 463–477.

304. Douketis J., Foster G., Crowther M. et al. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch. Intern. Med. 2000; 160: 3431–3436.

305. Hutten B.A., Prins M.H., Gent M. et al. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J. Clin. Oncol. 2000; 18: 3078–3083.

306. Lee A.Y. Treatment of venous thromboembolism in cancer patients. Thromb. Res. 2001; 102: 195–208.

307. Jarrett B.P., Dougherty M.J., Calligaro K.D. Inferior vena cava filters in malignant disease. J. Vasc. Surg. 2002; 36: 704–707.

308. Agency for Health Care Policy and Rearch (AHCPR)/ Clinical practice guideline 92-0032. Rockville, Maryland: Agency for Healthcare Policy and Rearch Hublications, 1992.